Overcoming IGF1R-Mediated Resistance to Oncolytic HSV1 and Radiotherapy via Triple Combination Therapy
Ji Young Yoo(The University of Texas MD Anderson Cancer Center), Jiyeon Kim, Jin Muk Kang(The University of Texas Health Science Center at Houston), Minhye Noh(The University of Texas Health Science Center at Houston), Stephanie M Bean(The University of Texas Health Science Center at Houston), E. Antonio Chiocca(Brigham and Women's Hospital), Grace Nguyen(The University of Texas Health Science Center), Tae Jin Lee(The University of Texas Health Science Center), Minxin Huang(The University of Texas Health Science Center), Sunil Krishnan(The University of Texas Health Science Center at Houston), Alexandra Miller(Mayo Clinic), Amanda Kouaho(The University of Texas Health Science Center at Houston), Zhongming Zhao(Vanderbilt University)
Cited by 0
Related Papers
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
|Cell Reports|2018|1.3k
Computational tools for copy number variation (CNV) detection using next-generation sequencing data: features and perspectives
|BMC Bioinformatics|2013|593
Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers
|Cell Reports|2018|396
Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth
|Cancer Cell|2015|336
Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis
|Clinical Cancer Research|2016|332